Plan: OPEN | Option: Dividend | Sailesh Raj Bhan

27 Mar 24 | 12:00 AM

107.98 -0.05 (-0.05%)

  • Underperforms

    57.66%

    Return (1Y)

    underperformed by -2.95%

  • Less Volatile

    0.68%

    Standard Deviation (1Y)

    Lower than by -0.23%

  • Not so consistent

    5/12

    Months

    Has beaten

  • Value research rating

    Not Rated

Critical Parameters

Everyone of us wants to create wealth by investing in top funds. Have a look at the key parameters that you need to check before deciding to invest in a mutual fund.

Returns

In last 1 year Nippon India Pharma Fund (IDCW), has underperformed its benchmark, by -2.95% (CAGR difference)

57.66%

Underperforms

This is +ve Alpha

Performance Chart for Rs

Invested in

Risk

In last 1 year , the volatility of Nippon India Pharma Fund (IDCW),is Lower than its benchmark, by -0.23%

0.68%

Less Volatile

Risk Meter

Peer Comparison on Risk - Return

Consistency

For 5 out of Last 12 Months, i.e 41.67% of the times It has beaten its benchmark,

Consistency Meter

Outperforming Stocks Vs. Underperforming Stocks

Based on the last 1year analysis, currently there are, 25 Stocks beating the benchmark 6 Stocks not beating the benchmark

View Stock Composition